MOLN Molecular Partners AG

NASDAQ
$4.21

Molecular Partners AG (MOLN) is expected to report earnings on August 26, 2026, after the market close. The consensus earnings estimate is a loss of $0.45 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +7.1% since its last earnings release on May 12, 2026.

Molecular Partners AG Missed Consensus Estimates
Tuesday, May 12, 2026 · 4:00 PM ET
Earnings Date
2nd Quarter, Jun 2026
Aug 26
Wednesday · 4:00 PM ET
Earnings Whisper
-
vs ($0.45)
Rev est $28.14M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.93

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Molecular Partners AG

Molecular Partners AG is a clinical-stage biotech company developing DARPin therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot.

Sector

Healthcare

Industry

Biotechnology